KPC Pharmaceuticals (SHSE:600422) Valuation Rank


SHSE:600422 KPC Pharmaceuticals Inc SHSE:600422
66 GF Score
Price ¥8.78
GF Value ¥11.91
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is KPC Pharmaceuticals Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

KPC Pharmaceuticals Valuation Rank Related Terms

SHSE:600422
66GF Score
KPC Pharmaceuticals Inc SHSE:600422
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KPC Pharmaceuticals (SHSE:600422) Overvalued in 2026?

Based on GuruFocus' analysis, KPC Pharmaceuticals stock appears to be undervalued. The current stock price of ¥8.78 is trading 26.3% below its estimated GF Value™ of ¥11.91. GuruFocus considers KPC Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for SHSE:600422:

  • Valuation Rank:
  • GF Value™: ¥11.91 vs. price of ¥8.78 (26.3% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600422 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KPC Pharmaceuticals Business Description

Address No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
66GF Score

Get the complete analysis for SHSE:600422

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.78
Price
¥11.91
GF Value